The Japanese company, which is trying to diversify its business, is said to be preparing to announce a $900 million deal to acquire the American testing company Ambry Genetics.
from NYT > Technology http://ift.tt/2sFXy8Y
from NYT > Technology http://ift.tt/2sFXy8Y
Comments
Post a Comment